OXADIAZOLINE LIGANDS FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX
申请人:RheoGene Holdings Inc.
公开号:EP1601354A2
公开(公告)日:2005-12-07
EP1601354A4
申请人:——
公开号:EP1601354A4
公开(公告)日:2009-08-12
US3939147A
申请人:——
公开号:US3939147A
公开(公告)日:1976-02-17
[EN] OXADIAZOLINE LIGANDS FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX<br/>[FR] LIGANDS D'OXADIAZOLINE POUR LA MODULATION DE L'EXPRESSION DE GENES EXOGENES VIA UN COMPLEXE RECEPTEUR D'ECDYSONE
申请人:RHEOGENE HOLDINGS INC
公开号:WO2005017126A2
公开(公告)日:2005-02-24
The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.